IVDU stands for “intravenous drug use” and refers to the practice of injecting substances directly into a vein using a needle and syringe. You will most often encounter this abbreviation in medical charts, hospital discharge summaries, and clinical literature, where it flags a specific route of substance administration that carries a distinct set of health risks. Although the acronym sometimes appears as shorthand for “intravenous drug user,” referring to the person rather than the behavior, that usage has become increasingly controversial in healthcare settings because of the stigma it attaches to patients.
Where You Will See the Term
IVDU shows up almost exclusively in clinical documentation. Emergency department notes, infectious disease consultations, cardiology workups, and surgical reports all use it as a shorthand to alert other providers that a patient’s medical situation may involve complications tied to injecting. If a patient is admitted with a heart valve infection, for instance, a note reading “history of IVDU” tells the cardiology team to look for patterns typical of injection-related endocarditis rather than other causes. The term functions as clinical shorthand that quickly orients a care team toward a particular set of diagnostic possibilities.
Outside of clinical settings, researchers and public health agencies increasingly prefer “people who inject drugs,” often abbreviated PWID. This person-first phrasing separates the individual from the behavior. A growing body of evidence suggests that stigmatizing labels in medical records can shape how clinicians perceive and treat patients, potentially influencing pain management decisions and the overall quality of care.1JACCP: Journal of the American College of Clinical Pharmacy. Characterizing Stigmatizing and Biased Language in Clinical Pharmacist Documentation You may see both IVDU and PWID in the literature, and understanding that they refer to the same behavior helps when reading medical records or research summaries.
Why the Intravenous Route Matters Medically
Injecting a substance into a vein delivers it directly to the bloodstream, bypassing all the body’s natural absorption barriers. When you swallow a pill, the drug passes through the stomach and liver before reaching general circulation, and a significant portion is broken down along the way. When you inject intramuscularly, the drug still has to diffuse through tissue. Intravenous delivery skips all of that. The drug reaches the brain in seconds, producing a faster and more intense effect than any other route.2PubMed Central. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection
That speed is precisely what makes IV use both intensely reinforcing for the user and medically dangerous. The rapid onset leaves almost no margin for error in dosing. It also means that anything mixed in with the drug, whether that is bacteria from unsterile preparation, particulate matter from a crushed tablet, or a toxic adulterant, enters the bloodstream all at once and travels immediately to the heart, lungs, and brain.
Bloodborne Infections
Sharing needles and injection equipment is one of the most efficient ways to transmit bloodborne viruses. Hepatitis C is by far the most commonly transmitted infection among people who inject drugs. A prospective study of young adults who injected drugs in San Francisco estimated that each shared needle event carried roughly a 0.25% chance of hepatitis C transmission on average, rising to about 1% among those who went on to acquire any HCV infection during follow-up.3Open Forum Infectious Diseases. Per-Contact Infectivity of Hepatitis C Virus Acquisition in Association With Receptive Needle Sharing Exposures in a Prospective Cohort of Young Adult People who Inject Drugs in San Francisco, California Those numbers sound small per event, but they accumulate quickly over months and years of repeated sharing. A study of needle-sharing incidents in Australian prisons found a 14% hepatitis C seroconversion rate among susceptible individuals within just over a year of a known exposure.4PubMed. Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons
HIV transmission through shared injection equipment is also well documented, though per-event transmission probability is lower than for hepatitis C. Hepatitis B rounds out the trio of major bloodborne viruses associated with IVDU. Beyond viruses, bacteria and fungi from skin, water used to dissolve drugs, or the drugs themselves can enter the bloodstream during injection, setting the stage for serious systemic infections.
Heart Valve Infections
Infective endocarditis, an infection of the heart’s inner lining and valves, is one of the most feared complications of intravenous drug use. Bacteria introduced through a needle first travel through the veins to the right side of the heart, which is why right-sided endocarditis, especially infection of the tricuspid valve, is strongly associated with IVDU. Staphylococcus aureus is the dominant culprit organism in these cases.5PubMed Central. Tricuspid valve endocarditis
Right-sided endocarditis can send infected clumps of bacteria into the lungs, causing abscesses and respiratory symptoms that sometimes lead to the initial diagnosis. Left-sided endocarditis, while less classically associated with injection drug use, also occurs and carries a higher mortality rate. Treatment typically requires weeks of intravenous antibiotics and, in severe cases, surgical valve replacement. For hospitalized patients with opioid use disorder, treatment for the underlying addiction during the same admission appears to improve outcomes. One study found that receiving medications for opioid use disorder was associated with roughly 70% lower mortality risk during the months the medication was actively being taken.6JAMA Network Open. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use–Associated Infective Endocarditis
Vascular Damage
Repeated injections into the same veins cause cumulative damage. Veins can become scarred, collapsed, or chronically inflamed, which is why people who have injected for a long time often shift to increasingly dangerous injection sites, including the groin, neck, and feet. Injecting into the femoral vein in the groin carries a particularly high risk of hitting the femoral artery, which can lead to pseudoaneurysms, essentially false bulges in the arterial wall that can rupture and bleed catastrophically. These often become infected and require urgent surgery.7PubMed Central. Management of femoral pseudo-aneurysm in intravenous drug abusers: 20-years experience
Deep vein thrombosis is another vascular complication. Damaged vein walls and sluggish blood flow create conditions favorable for clot formation. If a clot breaks loose and travels to the lungs, it becomes a pulmonary embolism, a potentially life-threatening emergency. Chronic venous insufficiency, where damaged veins can no longer efficiently return blood to the heart, can cause lasting swelling, skin changes, and ulcers in the legs.
Lung Damage From Crushed Tablets
When people crush oral medications and inject them, they introduce insoluble filler materials into their bloodstream. Tablets commonly contain talc, microcrystalline cellulose, and other binders that are harmless when swallowed but dangerous when injected. These particles are too large to pass through the lungs’ tiny blood vessels, so they become trapped there, triggering a foreign-body immune reaction called granulomatous inflammation. Over time, this can progress to pulmonary arterial hypertension, a serious condition where the blood pressure in the lung arteries climbs dangerously high, forcing the heart to work harder and eventually weakening it.8PubMed Central. Pulmonary Arterial Hypertension Due to Talc Granulomatosis Following Intravenous Use of Oral Medications: A Report of a Rare Case
This complication, sometimes called pulmonary talcosis, is relatively rare but can be devastating. It tends to develop silently over months or years and may not be recognized until the person presents with unexplained shortness of breath. On imaging, the tiny talc deposits can sometimes be visible as scattered bright spots in the lungs.
Cotton Fever
Cotton fever is a distinctive short-lived illness that people who inject drugs know well, even if their doctors sometimes do not. It refers to an acute febrile reaction that occurs after injecting through a cotton filter. Many people who inject drugs use small pieces of cotton to filter out particulate matter before drawing the solution into a syringe. The leading explanation is that a gram-negative bacterium called Enterobacter agglomerans, which commonly colonizes raw cotton, releases endotoxins into the solution that then enter the bloodstream.9PubMed Central. Just a Bad Case of Cotton Fever: A Case Report and Literature Review
The symptoms hit fast, typically within 15 to 30 minutes of injection: high fever, rigors (severe shaking chills), nausea, headache, and muscle pain. The illness is alarming but usually resolves on its own within hours. The clinical challenge is that cotton fever looks nearly identical to early sepsis or bacteremia, which are genuinely life-threatening. Emergency physicians seeing a patient with high fever and a history of recent injection must decide whether to treat aggressively for possible bloodstream infection or to observe, and the safer bet is almost always to treat first and reassess once blood cultures come back.10JEM Reports. Cotton fever: A case report and review of the literature
Overdose Risk and the IV Route
The same rapid delivery that makes intravenous use intensely reinforcing also compresses the window for recognizing and responding to an overdose. With opioids, the critical danger is respiratory depression. Opioids suppress breathing by acting on specific areas in the brainstem that control respiratory rhythm. When a full opioid like heroin, morphine, or fentanyl is injected intravenously, this suppression can set in within seconds to minutes, sometimes before the person even finishes the injection.11PubMed. Non-analgesic effects of opioids: opioid-induced respiratory depression
Naloxone, the reversal agent carried by first responders and increasingly by bystanders, works by knocking opioids off their receptors. It is effective for full agonists like fentanyl and heroin, but its half-life is short, around 30 minutes, which means that a person revived from an overdose of a long-acting opioid can slip back into respiratory depression once the naloxone wears off. This is a practical reality that matters for anyone who might use naloxone in a real-world situation: staying with someone after administering it and calling emergency services is essential.
Xylazine and the Changing Drug Supply
The illicit drug supply has become increasingly unpredictable, and one of the most troubling recent additions is xylazine, a veterinary sedative that has no approved use in humans. Xylazine has been showing up as an adulterant in fentanyl and heroin in much of the United States. It causes severe skin necrosis, including at sites distant from the actual injection point, which distinguishes it from ordinary injection-site wounds. Case reports describe painful, well-demarcated necrotic ulcers that require surgical debridement.12PubMed Central. Xylazine-induced acute skin necrosis in two patients who inject fentanyl
The mechanism appears to involve vasoconstriction. Xylazine activates alpha-2 adrenergic receptors, which narrows blood vessels and reduces blood flow to the skin and surrounding tissue. The resulting ischemia, or oxygen starvation, causes tissue to die. Critically, xylazine is not an opioid, which means naloxone does not reverse its sedative effects. When someone overdoses on a fentanyl-xylazine combination, naloxone can reverse the opioid component, but the person may remain dangerously sedated from the xylazine, complicating rescue efforts.
Kidney Disease From Chronic Infection
A less well-known long-term complication of IVDU is secondary amyloidosis, specifically a type called AA amyloidosis. This occurs when chronic, recurring soft-tissue infections, abscesses, and wounds cause the body to produce a protein called serum amyloid A as part of its inflammatory response. Over years of persistent infection, fragments of this protein can accumulate in organs, particularly the kidneys. The damage typically presents as severe proteinuria, where the kidneys leak large amounts of protein into the urine, and progresses to advanced kidney failure.13QJM: An International Journal of Medicine. Renal amyloidosis in intravenous drug users
This complication is not caused by the drug itself but by the body’s prolonged inflammatory response to repeated infections. It represents the kind of cascading, slow-building damage that makes long-term IVDU so medically complex: one complication feeds another, and the downstream effects can show up in organ systems seemingly unrelated to the original behavior.
Pregnancy and Injection Drug Use
When a pregnant person injects drugs, the clinical picture becomes more complicated on multiple fronts. Opioid dependence during pregnancy requires careful management because abrupt withdrawal can be dangerous for the fetus. The standard of care is typically medication-assisted treatment with methadone or buprenorphine rather than attempting full detoxification. Bloodborne infection risk, particularly hepatitis C and HIV, adds another layer of screening and treatment considerations. Neonatal abstinence syndrome, where the newborn experiences withdrawal symptoms after delivery, is a common outcome that requires specialized neonatal monitoring and care.14PubMed Central. Pregnancy and injecting drug use
The management of pregnant patients with IVDU histories generally calls for a multidisciplinary team involving obstetricians, addiction specialists, neonatologists, and social workers. Stigma in clinical settings can be a significant barrier to pregnant people seeking care, which makes the language debate around terms like IVDU more than an academic exercise.
Needle and Syringe Programs
Needle and syringe programs, often called syringe service programs in the United States, are among the most well-studied harm reduction interventions. The core idea is straightforward: providing sterile injection equipment reduces the sharing of contaminated needles, which reduces the transmission of bloodborne infections. A systematic review of structural-level needle-syringe programs found consistent evidence that they decrease both HIV and hepatitis C infection rates at the population level.15PubMed Central. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review
Mobile programs, which operate from vans or outreach vehicles and bring services directly to areas where people inject, have expanded the reach of these interventions, particularly in underserved and rural communities.16PubMed Central. Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact Beyond distributing clean equipment, many of these programs also offer naloxone, wound care, testing for bloodborne infections, and connections to treatment for substance use disorder. They function as a point of contact between a medically underserved population and the healthcare system.
What Happens When Patients Leave the Hospital Early
One of the persistent challenges in treating IVDU-related complications is that hospitalized patients with opioid use disorder frequently leave before their treatment is complete. Weeks of intravenous antibiotics for endocarditis, for example, require staying in the hospital or transitioning to a stable outpatient infusion setting, and untreated withdrawal symptoms or cravings make that difficult. A large analysis of over 127,000 hospitalizations found that starting medications for opioid use disorder early in the admission was associated with a meaningfully lower risk of patients leaving against medical advice, compared to providing no withdrawal treatment at all.17PubMed Central. Association of Early Opioid Withdrawal Treatment Strategy and Patient-Directed Discharge Among Hospitalized Patients with Opioid Use Disorder
Interestingly, the type of early treatment mattered. Medications specifically designed for opioid use disorder, such as buprenorphine or methadone, reduced early departures, while adjunctive medications alone, things like clonidine for withdrawal symptoms without an actual opioid agonist, were associated with a slightly higher risk of the patient leaving. This finding underscores a broader clinical reality: treating the addiction alongside the acute medical problem is not a luxury or a secondary concern. It is often the difference between completing a lifesaving course of treatment and walking out the door mid-treatment into a situation that is likely to bring the person right back to the emergency department.